Tosi Laura L, Sapp Julie C, Allen Elizabeth S, O'Keefe Regis J, Biesecker Leslie G
Division of Orthopaedic Surgery and Sports Medicine, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010 USA ; Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD USA.
J Child Orthop. 2011 Oct;5(5):319-27. doi: 10.1007/s11832-011-0350-6. Epub 2011 May 28.
A multidisciplinary workshop was convened at the National Institutes of Health (NIH) to discuss the management of the orthopedic and other complications of Proteus syndrome (PS), a progressive, disproportionate overgrowth disorder. While PS poses many complex challenges, the focus of the workshop was the management of the asymmetric and disorganized skeletal overgrowth that characterizes this multisystem disorder.
Workshop participants developed recommendations for clinical research and patient management and surveillance to maximize the benefits and reduce the risks of surgical and other interventions.
Recommendations for clinical care and management included assessments of skeletal overgrowth and its progression with modalities such as X-ray, magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry, and computerized tomography (CT) imaging. The recommendations also cover the assessment of non-orthopedic complications of PS that significantly impact surgical risk, such as pulmonary embolism and lung bullae. Surgical considerations in PS include assessment of the contribution of contractures to deformities and prophylactic soft-tissue release, aggressive and early use of epiphysiodesis and epiphysiostasis, amputation, and spinal bracing.
Decisions on the timing of orthopedic procedures in children with PS are challenging because they entail balancing the risks of intervention in this high-risk and complex population against the increasing morbidity that patients experience with progressive bony overgrowth. If surgery is delayed too long, the condition may become inoperable. We hope that these recommendations will help clinicians gather appropriate data and assist their patients in making timely treatment decisions.
美国国立卫生研究院(NIH)召开了一次多学科研讨会,以讨论变形综合征(PS)的骨科及其他并发症的管理,PS是一种进行性、不成比例的过度生长疾病。虽然PS带来了许多复杂挑战,但研讨会的重点是管理这种多系统疾病所特有的不对称且紊乱的骨骼过度生长。
研讨会参与者制定了临床研究、患者管理及监测的建议,以最大限度地提高手术及其他干预措施的益处并降低风险。
临床护理和管理建议包括通过X射线、磁共振成像(MRI)、双能X射线吸收法和计算机断层扫描(CT)成像等方式评估骨骼过度生长及其进展情况。这些建议还涵盖了对显著影响手术风险的PS非骨科并发症的评估,如肺栓塞和肺大疱。PS的手术考量包括评估挛缩对畸形的影响以及预防性软组织松解、积极早期使用骨骺阻滞术和骨骺固定术、截肢以及脊柱支具治疗。
对于患有PS的儿童,骨科手术时机的决策具有挑战性,因为这需要在这个高风险且复杂的人群中权衡干预风险与患者因进行性骨过度生长而增加的发病率。如果手术延迟过长,病情可能会变得无法手术治疗。我们希望这些建议将有助于临床医生收集适当的数据,并协助他们的患者做出及时的治疗决策。